Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Hemangiosarcoma × RNA, Messenger × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hemangiosarcoma 1

Interventions

belinostat 2 Doxorubicin 2 spartalizumab 1 ribociclib 1 pembrolizumab 1 peginterferon alfa-2a 1 cixutumumab 1 balstilimab 1 Radiotherapy 1 RNA, Messenger 1 Paclitaxel 1 Ipilimumab 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Fluorouracil 1 Filgrastim 1 Chemotherapy, Adjuvant 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05799612 2026-02-13

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

M.D. Anderson Cancer Center

Phase 1 Withdrawn

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡